Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

被引:22
|
作者
Murata, Masaharu [1 ,2 ]
Narahara, Sayoko [2 ]
Umezaki, Kaori
Toita, Riki [2 ]
Tabata, Shigekazu
Piao, Jing Shu
Abe, Kana
Kang, Jeong-Hun [3 ]
Ohuchida, Kenoki [4 ]
Cui, Lin
Hashizume, Makoto [2 ]
机构
[1] Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan
[3] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Osaka, Japan
[4] Kyushu Univ, Grad Sch Med Sci, Dept Surg Oncol, Fukuoka 812, Japan
来源
关键词
protein nanocages; drug delivery system; hepatocyte cell lines specific; hepatitis B virus; HEAT-SHOCK-PROTEIN; DRUG-DELIVERY SYSTEMS; METHANOCOCCUS-JANNASCHII; COATED PIT; IN-VITRO; RECEPTOR; BINDING; NANOPARTICLES; PATHWAYS; CANCER;
D O I
10.2147/IJN.S31365
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Protein nanocages are self-organized complexes of oligomers whose three-dimensional architecture can been determined in detail. These structures possess nanoscale inner cavities into which a variety of molecules, including therapeutic or diagnostic agents, can be encapsulated. These properties yield these particles suitable for a new class of drug delivery carrier, or as a bioimaging reagent that might respond to biochemical signals in many different cellular processes. We report here the design, synthesis, and biological characterization of a hepatocyte-specific nanocage carrying small heat-shock protein. These nanoscale protein cages, with a targeting peptide composed of a preS1 derivative from the hepatitis B virus on their surfaces, were prepared by genetic engineering techniques. PreS1-carrying nanocages showed lower cytotoxicity and significantly higher specificity for human hepatocyte cell lines than other cell lines in vitro. These results suggested that small heat-shock protein-based nanocages present great potential for the development of effective targeted delivery of various agents to specific cells.
引用
收藏
页码:4353 / 4362
页数:10
相关论文
共 50 条
  • [41] RELATIONSHIP OF SERUM PRES1 ANTIGEN CONCENTRATION TO INFECTIVITY OF HEPATITIS-B VIRUS (HBV) CARRIER MOTHERS
    MIMMS, L
    WHITTERS, E
    KUHNS, M
    ROSENLOF, R
    TYNER, J
    LELIE, P
    IP, H
    WRAY, L
    EBLE, K
    HEPATOLOGY, 1988, 8 (05) : 1326 - 1326
  • [42] THE PRES1 PROTEIN OF HEPATITIS-B VIRUS IS ACYLATED AT ITS AMINO TERMINUS WITH MYRISTIC ACID
    PERSING, DH
    VARMUS, HE
    GANEM, D
    JOURNAL OF VIROLOGY, 1987, 61 (05) : 1672 - 1677
  • [43] Adjuvant Effect of B Domain of Staphyloccocal Protein A Displayed on the Surface of Hepatitis B Virus Capsid
    Kim, Hyun Jin
    Ahn, Keum-Young
    Bae, Kyung Dong
    Lee, Jiyun
    Sim, Sang Jun
    Lee, Jeewon
    BIOTECHNOLOGY AND BIOENGINEERING, 2016, 113 (02) : 268 - 274
  • [44] Receptor-mediated endocytosis of hepatitis B virus PreS1 protein in EBV-tansformed B-cell line
    Park, JH
    Cho, EW
    Lee, DG
    Park, JM
    Lee, YJ
    Choi, EA
    Kim, KL
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2000, 10 (06) : 844 - 850
  • [45] Cloning and expression of the preS1 gene of hepatitis B virus in yeast cells
    Yin-Ying Lu
    Ke Li
    Jun Cheng
    Lin Wang
    Yan Liu
    Ling-Xia Zhang From the Gene Therapy Research Center
    Hepatobiliary & Pancreatic Diseases International, 2002, (02) : 238 - 242
  • [46] THE ROLE OF PRES1 IN THE INTERACTION OF HEPATITIS-B VIRUS WITH HUMAN HEPATOCYTES
    PONTISSO, P
    ALBERTI, A
    HEPATOLOGY, 1991, 14 (02) : 405 - 405
  • [47] Transactivation of transforming growth factor α gene by hepatitis B virus preS1
    Ono, M
    Morisawa, K
    Nie, J
    Ota, K
    Taniguchi, T
    Saibara, T
    Onishi, S
    CANCER RESEARCH, 1998, 58 (09) : 1813 - 1816
  • [48] Screening the hepatitis B virus PreS1 associated protein by the yeast two-hybrid system
    李丹
    王小众
    陈治新
    黄月红
    中华肝脏病杂志, 2003, (06) : 15 - 18
  • [49] Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection
    Hayashi, Yuka
    Tajiri, Kazuto
    Ozawa, Tatsuhiko
    Angata, Kiyohiko
    Sato, Takashi
    Togayachi, Akira
    Nagashima, Izuru
    Shimizu, Hiroki
    Murayama, Aiko
    Muraishi, Nozomu
    Narimatsu, Hisashi
    Yasuda, Ichiro
    MEDICINA-LITHUANIA, 2024, 60 (08):
  • [50] Impact of Genetic Variability in the PreS1/S2 and Hepatitis B Surface Antigen (HBsAg) Regions of the Hepatitis B Virus (HBV) on Quantitative HBsAg Levels
    Kitrinos, Kathryn M.
    Chan, Henry Lik-Yuen
    Gane, Edward J.
    Fung, Scott
    Dinh, Phillip
    Lin, Lanjia
    Corsa, Amoreena C.
    Miller, Michael D.
    Subramanian, Mani
    Thompson, Alexander J.
    Buti, Maria
    HEPATOLOGY, 2013, 58 : 712A - 712A